Gummi World Completes the Supplement Safety and Compliance Initiative audit

Gummi World Completes the Supplement Safety and Compliance Initiative audit

The SSCI audit is a testament to Gummi World’s commitment to producing supplements of high quality, safety, and trustworthiness for brands as well as consumers.

Gummi World is the largest nutraceutical company in the world and a subsidiary of Intiva.

It has successfully passed The Supplement Safety & Compliance Initiative Audit, an initiative driven by the retail industry to improve standards for quality, safety and compliance with regulatory requirements across the entire supplement industry. Gummi World is proud to manufacture safe, effective, and ethical products that help brands build a reputation in a competitive market. Gummi World’s participation in the SSCI Audit further demonstrates its commitment to maintain the highest quality of products, which brands and consumers can trust.

SSCI’s goal is to improve the global supplement industry through reducing risks of safety and compliance, creating standards that are consistent around the world, and encouraging experts in the field. The organization urges manufacturers, retailers and suppliers to work together on best practices, which not only promote consistent standards but streamline certification processes, which reduce costs and increase operational efficiency.

Gummi World’s pursuit of SSCI through SGS highlights its efforts to enhance the safety, authenticity, and quality for dietary supplements worldwide. Our entire process is guided by strict standards to ensure effectiveness and consistency.

There is a great deal of confusion regarding the safety of dietary supplement and their regulatory compliance. SSCI helps to promote transparency and track industry progress and builds trust between brands and customers.

We are a company committed to industry best practices and we partner with SSCI in order to influence a more trustworthy, safer industry”, said Ayan Montpara, CMO at Gummi World.

Gummi World is the only nutraceutical company in the world to hold multiple international certifications, including NSF Certified for Sport (r), NSF Health Sciences Certification Program, GFCO Gluten Free Certification, USP Certified and USDA Organic Certified. Gummi World was the first manufacturer in the world to receive NSF/ANSI-455-4 OTC drug manufacturing certification. Gummi World’s in-house R&D, advanced manufacturing, custom formulations and certifications allow brands to quickly launch products with strict regulatory compliance.

Monpara added that Gummi World offers flexible packaging, private labeling solutions, quick turnaround times and ingredient options such as vegan and no added sugar.

Gummi World continues to invest in manufacturing technology, compliance with regulatory standards, and infrastructure of high quality to support emerging brands as well as established global companies looking for reliable manufacturing partners. Initiatives like SSCI, which are a part of the evolving supplement industry, help to align brands with manufacturers and customers. After a successful audit Gummi World has now reached the last stage in obtaining SSCI Certification, which will add to the growing portfolio of certifications. Visit gummiworld.com to learn more about Gummi World’s manufacturing capabilities and quality assurance commitment.

The Gummi World

Intiva Health revolutionizes the healthcare industry through innovation in technology, compliance and wellness.

Intiva delivers innovative solutions in multiple industries as the parent company for Incredable Wellness Centers and Nova Vita Wellness Centers. With an innovative digital platform, Incredable simplifies the credentialing of providers and their compliance. Gummi World is the leading nutraceutical producer in the world. They ensure unmatched safety and quality in their custom-made gummies and supplements. Nova Vita Wellness Centers offer advanced therapies for regenerative healthcare, such as IV infusions and peptides.

These companies transform healthcare through improved efficiency, access, and outcomes for patients.

View Article Source